Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Optimal Foraging00:48

Optimal Foraging

14.0K
How animals obtain and eat their food is called foraging behavior. Foraging can include searching for plants and hunting for prey and depends on the species and environment.
14.0K
Optimization Problems01:26

Optimization Problems

80
Optimization problems often involve identifying maximum or minimum values under specific constraints. A well-known example is determining the longest horizontal pipe that can be moved around a right-angled corner, where a 3-meter-wide hallway meets a 2-meter-wide hallway. This scenario, common in architectural design and industrial transport, can be understood conceptually through geometric and trigonometric reasoning.To visualize the problem, consider the pipe as a straight line that touches...
80
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Optimal Arousal Theory01:23

Optimal Arousal Theory

888
The optimal arousal theory suggests that performance is maximized when an individual experiences a moderate level of arousal. This theory is closely tied to the Yerkes-Dodson law, which illustrates an inverted U-shaped relationship between arousal and performance. The law, formulated by psychologists Robert Yerkes and John Dodson, implies an ideal arousal level for optimal performance, and deviations from this level can lead to declines in effectiveness.
Inverted U-Shaped Performance Curve
The...
888
Unrealistic Optimism Bias01:30

Unrealistic Optimism Bias

245
Unrealistic optimism bias is the tendency to overestimate the likelihood of positive outcomes. This cognitive bias makes individuals believe they are less likely to experience failures, setbacks, or risks and more likely to succeed than others. For example, people may assume they are less prone to health issues, accidents, or financial struggles than their peers, even when they share similar risk factors.One key component of this bias is the above-average effect, where individuals perceive...
245

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy.

The oncologist·2025
Same author

Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden.

Journal of the National Cancer Institute·2025
Same author

Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial Intelligence.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy.

JCO clinical cancer informatics·2024
Same author

2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023
Same author

2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023

Related Experiment Video

Updated: Feb 13, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
11:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

8.6K

Getting it right the first time: recent progress in optimizing antiemetic usage.

Lee Schwartzberg1

  • 1West Cancer Center, Memphis, TN, USA. lschwartzberg@westclinic.com.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|March 21, 2018
PubMed
Summary

Effective antiemetic therapies, including serotonin (5-HT3) receptor antagonists, neurokinin-1 (NK-1) receptor antagonists, and olanzapine, have significantly improved chemotherapy-induced nausea and vomiting (CINV) management. These advancements enhance patient quality of life during cancer treatment.

Keywords:
5-HT3 receptor antagonistCINVChemotherapy-induced nausea and vomitingNK-1 receptor antagonistOlanzapineRadiotherapy-induced nausea and vomiting

More Related Videos

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K
Optimize Flue Gas Settings to Promote Microalgae Growth in Photobioreactors via Computer Simulations
14:33

Optimize Flue Gas Settings to Promote Microalgae Growth in Photobioreactors via Computer Simulations

Published on: October 1, 2013

14.9K

Related Experiment Videos

Last Updated: Feb 13, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
11:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

8.6K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K
Optimize Flue Gas Settings to Promote Microalgae Growth in Photobioreactors via Computer Simulations
14:33

Optimize Flue Gas Settings to Promote Microalgae Growth in Photobioreactors via Computer Simulations

Published on: October 1, 2013

14.9K

Area of Science:

  • Oncology
  • Pharmacology
  • Supportive Care

Background:

  • Chemotherapy-induced nausea and vomiting (CINV) significantly impacts patient quality of life and treatment adherence.
  • Recent advancements in antiemetic pharmacotherapy have led to substantial improvements in CINV prevention and management.
  • Key drug classes include serotonin (5-HT3) receptor antagonists, neurokinin-1 (NK-1) receptor antagonists, and olanzapine.

Purpose of the Study:

  • To review the advancements in antiemetic therapies for managing chemotherapy-induced nausea and vomiting (CINV).
  • To highlight the efficacy of novel antiemetic agents in improving patient outcomes during chemotherapy.
  • To discuss the integration of these therapies into the standard of care for CINV management.

Main Methods:

  • Review of clinical trial data and current literature on antiemetic therapies.
  • Analysis of the efficacy of serotonin (5-HT3) receptor antagonists, NK-1 receptor antagonists, and olanzapine.
  • Evaluation of combination therapies including dexamethasone and dopamine receptor antagonists.

Main Results:

  • Serotonin (5-HT3) receptor antagonists are effective for acute CINV.
  • NK-1 receptor antagonists and olanzapine show efficacy against both acute and delayed CINV.
  • Combination therapies are emerging as the standard of care for moderately to highly emetogenic chemotherapy.

Conclusions:

  • Modern antiemetic regimens have significantly improved CINV control and patient quality of life.
  • Understanding the specific profiles of antiemetic agents is crucial for optimal patient management.
  • Continued assessment of clinical data is necessary to refine CINV prevention and treatment strategies.